Mark Richards
← Back to National University Heart Centre Singapore
National University Heart Centre Singapore
Mark Richards works in Heart Failure Treatment and Management, Cardiac Fibrosis and Remodeling, Acute Myocardial Infarction Research, Cardiovascular, Neuropeptides, and Oxidative Stress Research, Cardiovascular Function and Risk Factors. Recorded institutional associations include National University of Singapore, Christchurch Hospital, National University Heart Centre Singapore.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
2000 · 1,376 citationsNT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients
2005 · 1,169 citationsHeart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
2019 · 804 citationsGlobal burden of cardiovascular diseases: projections from 2025 to 2050
2024 · 793 citationsPlasma N-Terminal Pro–Brain Natriuretic Peptide and Adrenomedullin
1998 · 646 citationsImmunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment
1997 · 514 citationsMid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea
2010 · 511 citationsPlasma brain natriuretic peptide in assessment of acute dyspnoea
1994 · 510 citationsB-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
2003 · 436 citationsA Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction
2021 · 401 citationsRENAL, HAEMODYNAMIC, AND HORMONAL EFFECTS OF HUMAN ALPHA ATRIAL NATRIURETIC PEPTIDE IN HEALTHY VOLUNTEERS
1985 · 400 citations2-Hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain Symptoms Using Contemporary Troponins as the Only Biomarker
2012 · 399 citationsPlasma N-terminal pro-brain natriuretic peptide and adrenomedullin
2001 · 389 citationsBrain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath
2003 · 372 citationsRight Ventricular Dysfunction in Left-Sided Heart Failure with Preserved Versus Reduced Ejection Fraction
2017 · 360 citationsN-Terminal Pro–B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure
2009 · 352 citationsPlasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction
2007 · 344 citationsValidation of High-Sensitivity Troponin I in a 2-Hour Diagnostic Strategy to Assess 30-Day Outcomes in Emergency Department Patients With Possible Acute Coronary Syndrome
2013 · 317 citationsPhysician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure
2010 · 316 citationsIncreased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis
2003 · 308 citationsRapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection
2017 · 290 citationsMortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study
2018 · 288 citationsEffect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
2014 · 275 citationsPlasma B-type natriuretic peptide levels in systolic heart failure
2004 · 271 citationsMetabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man
1986 · 267 citations
